Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsJoshua M. Francis, Matthew Meyerson, Adam Kieżun et al.|Nature Genetics|2013Cited by 374
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F. Fahrmann, Samir Hanash, C. Max Schmidt et al.|Gastroenterology|2020Cited by 199
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancerAna Babić, Brian M. Wolpin, Michael H. Rosenthal et al.|Nature Communications|2023Cited by 63
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Andrew J. Aguirre, Rachel B. Keller et al.|Clinical Cancer Research|2023Cited by 46